Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer

Heparin‐induced thrombocytopenia (HIT) is a serious adverse reaction to heparin treatment with a high risk of thrombosis. Heparin must be discontinued immediately and replaced with alternative anticoagulants that do not interact with HIT antibodies. In this case, a lung cancer patient, diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Pia Bükmann, Jørgensen, Maja, Friis‐Hansen, Lennart, Ingeberg, Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693689/
https://www.ncbi.nlm.nih.gov/pubmed/26732728
http://dx.doi.org/10.1002/ccr3.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693689/
https://www.ncbi.nlm.nih.gov/pubmed/26732728
http://dx.doi.org/10.1002/ccr3.411

Ejemplares similares